IL-BAI
8.12.2022 19:43:43 CET | Business Wire | Press release
BAI, a nonprofit independent organization that delivers the most actionable insights in financial services, has named ten organizational winners and one honorable mention for the 2022 BAI Global Innovation Awards. Ten individuals were also named BAI Rising Stars. The awards are the industry’s leading program celebrating achievements in innovation, such as pursuing bold solutions for improving customer experience; implementing advanced technologies; and improving the lives of employees, customers, and communities.
Winners were selected by the BAI Innovation Circle, a panel of distinguished judges from around the world who are at the forefront of innovation in the financial services sector. Collectively, the winners represent outstanding contributions by teams and individuals and showcase inspiration from around the world. These global trailblazers have successfully designed and delivered innovations that positively improved customer relationships and served their communities in powerful ways.
“Innovation is a significant driver of the impact that successful financial services companies have on their customers and communities. The industry continues to bring powerful new approaches and solutions to better meet customer needs in new and different ways,” said Debbie Bianucci, president and CEO of BAI and Innovation Circle Judge. “The companies and individuals recognized this year were particularly creative and focused on addressing practical issues that made meaningful improvements for customers and employees.”
The 2022 BAI Global Innovation Award Winners and Honorable Mention are:
Banco Popular (Puerto Rico)
Innovation in Learning & Development
Innovation: Talent Lab & Skills Accelerator
Bank of America (USA)
Innovation in Digital Security
Innovation: Bank of America Security Center
Dreams Technology (United Kingdom)
Innovation in Digital Financial Planning
Innovation: Dreams ESG Innovation
Growsari (Philippines)
Innovation in Digital Commercial Financing
Innovation: GROWSARI.com, Powering the Digital Economy of the Philippines
Money Management International, Inc. (USA)
Innovation in Community Disaster Recovery
Innovation: Project Porchlight by MMI
MVB Bank (USA)
Innovation in Commercial Banking Onboarding Experience
Innovation: Onboarding Fintechs Better, Faster, Stronger…The Victor (ad)Vantage
Payten Teknoloji A.S.-Paratika (Turkey)
Innovation in Payments
Innovation: Paratika Crowdfunding e-Payment Project
Standard Bank (South Africa)
Innovation in Community Sustainability
Innovation: One Farm Share
TIAA (USA)
Innovation in Fraud Prevention
Innovation: TIAA Phone Authentication Risk Management (PARM)
Union Bank of India (India)
Innovation in HR Transformation
Innovation: Union Prerna
BMO (USA)
Innovation in Diversity, Equity & Inclusion (Honorable Mention)
Innovation: True Name
To further recognize innovation in financial services, a new award was established in 2022 to recognize individual leaders. The BAI Rising Star Award honors individuals who are up-and-coming leaders in financial services innovation. Leaders were nominated by their organizations and the recipients of the BAI Rising Star Award were selected based on their impact on and passion for innovation and their ability to drive positive change in their organizations.
The 2022 BAI Rising Star Award Winners are:
Sachin Chandna (United Arab Emirates), SVP, Head of Customer Intelligence & Engagement – Emirates NBD
Geoff Ellis (USA), Senior Director Application Development – Ally Financial
Ashley Fiore (USA), Chief Business Intelligence Officer – KlariVis
Snigdha Kumar (USA), Head of Product Operations – Digit
Larricia Lumpkins (USA), SVP, Senior Strategy Manager – Citizens Financial Group
Niki Neumann (South Africa), Executive, Lead Ecosystem Agriculture – Standard Bank Group
Dr. Chetna Pandey (India), Deputy General Manager – Union Bank of India
Stacy Regnier (USA), SVP, Retail Strategic Programs and Business Transformation – Commerce Bank
Bradwin Roper (South Africa), CEO – FNB Connect
Paul Whelpton (South Africa), Group Analytics Officer and Group Head of Trading – JUMO
For more information about the winners and their innovations, visit https://www.bai.org/globalinnovations/.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221208005871/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Pelago Bioscience Acquires RG Discovery, Forming an Integrated Drug Discovery Partner Spanning Biology and Chemistry15.6.2026 09:00:00 CEST | Press release
The combination unites Pelago Bioscience’s industry-leading and proprietary cellular target engagement capabilities with RG Discovery’s deep medicinal chemistry and custom synthesis expertise - enabling customers to advance drug discovery programs across the full design-make-test-analyze-(DMTA) cycle with a single specialist partner. Pelago Bioscience, a specialist drug discovery focused contract research organization (CRO), known for its industry-leading cell-based target engagement assays, is pleased to announce the acquisition of RG Discovery, and thereby adding deep expertise in medicinal chemistry, custom synthesis, and integrated drug discovery. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260615340933/en/ Michael Dabrowski, Chief Executive Officer of Pelago Bioscience By combining Pelago Bioscience's biology-focused capabilities with RG Discovery's chemistry expertise, the enlarged platform will enable drug discover
LTM Launches BlueVerse™ for iRun to Outcreate Managed Services in the Agentic AI Era15.6.2026 08:10:00 CEST | Press release
AI-native operations model enables enterprises to move from reactive service delivery to intelligent, outcome-driven managed services LTM, the Business Creativity partner to the world’s largest enterprises, today announced the launch of BlueVerse™ for iRun, an AI-native managed services model designed to transform traditional IT operations into a resilient, intelligent, and outcome-driven operating model. As enterprise environments grow more complex—spanning hybrid cloud, SaaS, and AI-driven ecosystems—traditional managed services models are increasingly constrained by siloed teams, static processes, and effort-led scaling. BlueVerse for iRun addresses this shift by moving beyond headcount-based delivery to a platform-led approach powered by agentic AI, knowledge convergence, and process-as-code. Built on the BlueVerse ecosystem, iRun creates a unified intelligence layer that brings together enterprise data, telemetry, workflows, and operational context—enabling AI to reason across sys
Azafaros to Present at BIO International Convention 202615.6.2026 07:00:00 CEST | Press release
Azafaros, a private company building a portfolio to become a leader in lysosomal storage disorders (LSDs), focused on addressing neurological symptoms, today announced that it will present at the 2026 BIO International Convention taking place in San Diego, USA, from June 22-25. The company’s presentation is scheduled for Monday, June 22 at 4:30 PM in Theater 4. The presentation will highlight Azafaros’ progress in developing nizubaglustat, its lead investigational compound for the treatment of rare lysosomal storage disorders with neurological involvement, including GM1 and GM2 gangliosidoses (GM1/GM2) and Niemann-Pick type C disease (NPC). Nizubaglustat is currently in two Phase 3 registrational studies (NAVIGATE) treating patients with GM1/GM2 and NPC and expects to report topline data from the studies in 2028. “BIO provides an important opportunity to update our progress as we continue advancing nizubaglustat through late-stage clinical development,” said Stefano Portolano, CEO at A
Teledyne FLIR Defense Launches Black Recon™ Autonomous Micro-Drone15.6.2026 06:05:00 CEST | Press release
Autonomous launch, recovery, and recharge from military vehicles and fixed installations; Three-drone rotation provides persistent surveillance and real-time targeting data in contested environments Teledyne FLIR Defense, part of Teledyne Technologies Incorporated (NYSE: TDY), today announced at Eurosatory the market launch of Black Recon™, an autonomously launched micro-drone system that delivers continuous, untethered reconnaissance from military vehicles and fixed installations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260614388428/en/ Teledyne FLIR Defense announced at Eurosatory the market launch of Black Recon™, an autonomously launched micro-drone that delivers continuous, untethered reconnaissance from military vehicles and fixed installations. Black Recon allows crews to launch, operate, recover, and recharge up to three UAS without leaving their platform, reducing operator risk. Designed for vehicle integrati
OM Pharma to Unveil the Largest Multi-Country Real-World Evidence Study on Broncho‑Vaxom® (OM‑85) for RTI Prevention at EAACI 202614.6.2026 10:00:00 CEST | Press release
REACH study met its first primary endpoint, showing that Broncho‑Vaxom® (OM‑85) was associated with a 28-38% reduction in respiratory tract infection rates at 12 months and 29-41% reduction at 24 months, comparing post-treatment versus pre-treatment initiation.1 The reduction was observed regardless of the frequency of respiratory tract infections in the previous year (1-3, >3) and across age subgroups (1-5, 6-11, 12-17, 18-64, >64 years).1 By reflecting everyday clinical practice and capturing episodes that necessitated a visit to the doctor, these extensive data offer critical new evidence of the therapy’s long-term relevance for patients suffering from recurrent respiratory tract infections. Evaluating a vast cohort of more than 15,790 paediatric, adolescent, adult and elderly patients in China, Italy, and Belgium, REACH represents the largest and only multi-country real-world evidence study to date for Broncho-Vaxom®.1,2 The study cohort includes patients with different co-morbidit
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom